about
Highlights of the year in JACC 2012Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in SingaporeLevels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.Hormone replacement therapy in the prevention and treatment of atherosclerosis.Prevalence of insulin resistance in siblings of type 2 diabetics of north west punjabi population.The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events.Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients.Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice.Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events.Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.Production of Cloned Miniature Pigs Expressing High Levels of Human Apolipoprotein(a) in Plasma.Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a).Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.5' control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family.Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study.Lipoprotein(a): implications for clinical practice.Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urineSubendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.Fibrinogen deficiency is compatible with the development of atherosclerosis in mice.Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives.Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.Lipoproteins in heart disease.Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis.Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.Low-density lipoprotein apheresis: clinical results with different methods.Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly.Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice.The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in a tri-ethnic sample of women: The Cross-Cultural Activity Participation Study.The importance of serum lipoprotein (a) as an independent risk factor for premature coronary artery disease in middle-aged black and white women from the United States.Levels of lipoprotein(a) and plasma lipids in Spanish children aged from 4 to 18 years.Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect.Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus.The effect of long-term glycaemic control on serum lipoprotein(a) levels in patients with Type 2 diabetes mellitus.
P2860
Q26865608-06A1C91B-ED69-4492-A7DA-1D000B5C7C45Q30489063-8D921561-8F0D-464E-883E-16F70B083531Q33628079-AB3FE260-B586-4340-AAFB-886433859BEAQ33683302-D27A0F4E-37B8-47F2-9DA9-D9C1FA893BDBQ33704490-49E5D306-E5E1-435F-812B-8309E837FF4BQ33835341-B97C36EE-41F7-48C1-A1D4-42023C9135CFQ34107469-C80874C1-CC14-4A53-8C08-26F5E23DA039Q34310570-858E8B87-FD90-447E-A6B2-58587D813EBBQ34336831-8D1F0AFA-D4BC-4A74-893A-8CA5B74D6126Q35024656-4349F7AB-F9A5-4479-86D5-EDB93EA45F0FQ35094413-F4F65A65-8BA3-43DC-B267-0FCBCA2EB6C7Q35566923-1A9FDEA7-37E7-4C5C-929A-B915FA774161Q35566936-748ED620-3B18-47F7-8AE5-5CEFD997C9E8Q35683521-D6B33A12-1D2C-4897-ADDC-C0B4698F1BD1Q35763619-30F8D463-8502-4741-A373-76DB9EC6F976Q36059933-18760E92-4D68-4E4F-9C90-931DE44EBDD2Q36083881-12011CAB-3614-4FA6-B133-610950BC5F24Q36104114-1E1DF1E0-035B-4C05-8084-283BE814654EQ36185923-2A68D74F-7733-4CF6-A783-5C12B7337229Q36232356-62994ABB-E763-4DEA-A6E1-4723B244669AQ36383775-7996E417-EEA1-4E8D-9FC0-566A1F6046D2Q37361631-0ADE1429-9E54-49BA-A6D5-D62738FA4F6FQ37371207-EEAFDEE2-E508-41FA-B9E8-8662CCF5970BQ37379082-A8171EC1-5E2A-4FAD-84AB-1C06B282E4C2Q37593887-0813670D-A4C5-4F9A-86BD-AF98B115A875Q40056792-98A28F84-116B-43A0-ACD7-6D73453D3EA6Q40476568-87782605-264D-4F46-B080-9C95FF277AD2Q41181227-CE3AF7D8-57B8-41CA-851C-2770FE94ADE0Q41671750-D217F094-40AA-4DD5-B34E-807F2B55339BQ41921127-EEE628C1-6F20-4357-A061-EFFC228E83BFQ43905985-8B5CF249-CCDF-4B10-BE3B-E006F6A7D137Q43952010-C52A50F6-8448-46A9-AF25-3207C1AAD68EQ46067183-FB8D3C6B-1C3C-4E90-8B65-CC211D28C4A7Q46431843-60C2C16E-AA68-4FA5-A794-63E9C264B20AQ46465411-DA7ED34D-7792-4C24-97BB-E8BB962A06A3Q46646475-16112274-FCA8-4095-9A38-96DC2CEFC2CFQ47186327-B203278B-15A8-4351-817F-BD40FFF21330Q50661669-AB59D392-7428-438D-B668-364427DB22F6Q50912837-3EDBAE4C-6D0C-4850-8725-97897713C0F8Q51558534-34675B5D-947A-4E4B-A059-E6354F07F39B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipoprotein(a) and atherosclerosis.
@en
type
label
Lipoprotein(a) and atherosclerosis.
@en
prefLabel
Lipoprotein(a) and atherosclerosis.
@en
P2093
P921
P1476
Lipoprotein(a) and atherosclerosis.
@en
P2093
P304
P356
10.7326/0003-4819-115-3-209
P407
P577
1991-08-01T00:00:00Z